Public Board of Directors papers 241122

EXECUTIVE SUMMARY

Introduction

The Integrated Performance, Quality & Finance report presents a summary dashboard that provides an overview of performance.

Safe • No serious incidents were reported in October. There were 11 incidents reported in month with the classification of moderate, details of which can be found on slide 8 and 9. All the incidents are still progressing through to full root cause analysis. No never events were reported in month. • There are 5 Trust level risks scored at 15+. Details of these can be found on slide 12. • Safer staffing numbers have met the required acuity levels to ensure appropriate levels of safety and care for our patients. Indicative staffing, in line with nursing establishments, is set to maintain a 1:6 nurse to patient ratio. On occasion this has been extended to 1:8 which is in line with recommended national staffing ratios. While we have seen an increase in patient safety incidents, following thematic review, these were not related to nurse staffing ratios. Responsive • Performance against the 62 day standard has shown an improvement from September. The 62 day standard has not been met with a performance of 74.5%, subject to validation. The 62 day unvalidated upgrade performance is above the standard with a performance of 85.1%. The internal 24 day target has also met the standard and is at 85.5%. All 62 and 24 day breaches are reviewed to ensure any delays are understood and plans can be implemented to mitigate any future delays. All 31 day targets and 18 week RTT standards have been achieved in October subject to validation. Performance against the CWT thresholds is constantly monitored. • Referrals in October increased slightly from September and remain high. The overall trend continues to be significantly higher than the 21/22 average. • Activity levels are now monitored against agreed 22/23 plan. As at month 7 Chemotherapy deliveries and radiotherapy fractions along with non elective spells continue to be above plan whilst all other points of delivery are either on plan or tracking slightly below plan. Effective • There were 2 cases of C-Difficile and 5 cases of E-Coli in October that were deemed attributable to the Trust. No lapses in care have been identified. No other infections were recorded. • There were 15 cases of hospital acquired nosocomial Covid-19 infections in October. • Staff absence levels improved from September but remain over the target of 3.4%. • There continues to be improvement against the essential training threshold, however PDR performance has reduced from September and remains under the target of 84%. Well – Led • The trust is reporting a month 7 position of £58k surplus compared to a breakeven plan within the latest plan submission of an annual break even control total. • The month 7 I&E deficit is £8,912k, prior to adjusting for donated depreciation, charitably funded capital donations, donated grant income, donated consumables, transfers by absorption and impairments. • The cash balance is £161,426k. • Capital performance to month 7 is £5,9m below the proposed plan submitted to NHSE&I. The Paterson scheme is behind plan but still anticipated to meet plan by year end and conclude then. IFRS 16 leases which were anticipated to be contractually entered into by this point are yet to be committed. 32